<DOC>
	<DOCNO>NCT00163397</DOCNO>
	<brief_summary>The aim study investigate efficacy ciclesonide versus budesonide lung function , symptom use rescue medication patient asthma . Ciclesonide budesonide inhale daily one dose level . The study duration consist baseline period ( 1 4 week ) treatment period ( 12 week ) . The study provide data safety tolerability ciclesonide .</brief_summary>
	<brief_title>Efficacy Ciclesonide Versus Budesonide Patients With Asthma ( 18 75 ) ( BY9010/M1-137 )</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Ciclesonide</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Main During last 4 week prior baseline , treatment inhale steroid ( dosage : 250 mcg fluticasone propionate equivalent ) FEV1 80 105 % predict Healthy exception asthma Written inform consent obtain Outpatients Patients history persistent bronchial asthma least 6 month Main Concomitant severe disease disease contraindication use inhaled steroid Concomitant COPD ( i.e . chronic bronchitis emphysema ) and/or relevant lung disease cause alternate impairment lung function An asthma exacerbation infection lower airways prior entry baseline period Pregnancy Intention become pregnant course study Breast feeding Lack safe contraception Patient current smoker 10 packyears Patient exsmoker 10 packyears</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Ciclesonide</keyword>
	<keyword>Budesonide</keyword>
</DOC>